Capsid Proteins Characterization by Mass Spectrometry

While other methods infer identity based on physicochemical properties, mass spectrometry provides unambiguous confirmation by directly measuring the molecular weight and amino acid sequence of the capsid proteins (VP1, VP2, VP3). This unparalleled specificity makes it the gold standard for establishing molecular identity and the essential tool for in-depth characterization of AAV products.

Legacy: MALDI-TOF MS enabled early protein analysis but offered lower resolution and limited LC coupling.

Established: High-resolution LC-MS (Orbitrap, Q-TOF) is the current industry standard, combining HPLC separation with precise mass measurement.

Emerging: Top-down MS directly analyzes intact proteins, revealing PTM combinations, but remains technically challenging.

Mass spectrometry characterizes proteins based on their mass-to-charge (m/z) ratio. Intact mass analysis confirms molecular weight and relative abundance of VP1, VP2, VP3, while peptide mapping (after enzymatic digestion) confirms amino acid sequence and identifies PTMs.

The most common approach is 'bottom-up' peptide mapping, where the protein is first digested into smaller, more manageable peptides for analysis. In contrast, emerging 'top-down' methods attempt to analyze the entire intact protein directly, which is technically more challenging but preserves critical information about how different PTMs are combined on a single molecule.

• Output (Intact Mass): A deconvoluted mass spectrum showing peaks for VP1, VP2, and VP3. The report lists the measured molecular weight for each protein.
• Output (Peptide Mapping): Peptide mapping typically achieves >95% sequence coverage, providing high confidence in primary structure confirmation. PTMs are identified and localized within the sequence.
• Interpretation is a process of matching the experimental evidence from the mass spectrometer to the product's theoretical blueprint. The measured masses and peptide sequences serve as a molecular fingerprint that is compared against the expected values from the known amino acid sequence. A precise match provides definitive confirmation of identity, while any deviations are flagged as potential PTMs or impurities requiring further investigation.

• Definitive molecular weight and sequence confirmation.
• High sensitivity for low-level modifications/impurities.
• Rich information content—identity, PTMs, and ratios from one dataset.

• High Complexity: Requires highly skilled operators and significant expertise for method development and data interpretation.
• Expensive: The instrumentation represents a major capital investment.
• Low Throughput: May not be suitable for routine QC release testing due to the complexity and time required for analysis.
• Data Intensive: The raw data files are very large, and the analysis can be complex.

Validation of MS methods is complex and highly dependent on the intended purpose.

Identity (Peptide Mapping): Demonstrate high sequence coverage vs. theoretical sequence.

Quantification (Protein Ratio): Show precision, accuracy, and linearity; often supportive data only.

System Suitability: Confirm mass accuracy within tight tolerances (e.g., <5 ppm).

Standardization for mass spectrometry is fundamentally about ensuring the integrity and performance of the entire analytical system, from sample preparation to data analysis. This is anchored by two key pillars: rigorous control of instrument performance—especially mass accuracy, often held to a <5 ppm tolerance—and the consistent use of a well-characterized reference material. This reference material serves as a system suitability control, acting as the 'gold standard' positive control to verify that the method can correctly identify the expected protein masses, peptide sequences, and critical PTMs. Effective lifecycle management of this reference standard is therefore essential for ensuring data comparability across characterization and comparability studies throughout the product's development.

• AAV Gene Therapy: Defines capsid identity and structural integrity; essential for characterization packages though not routine release.
• mAbs & Proteins: Core platform for identity confirmation and PTM mapping (e.g., glycosylation, oxidation).